Gayer Charles K 4
4 · BIOCRYST PHARMACEUTICALS INC · Filed Dec 20, 2023
Insider Transaction Report
Form 4
Gayer Charles K
Vice President and CCO
Transactions
- Tax Payment
Common Stock
2023-12-19$6.05/sh−2,482$15,016→ 274,533 total
Footnotes (1)
- [F1]Represents shares withheld by the issuer to satisfy required tax withholding obligations in connection with the vesting of previously granted Restricted Stock Units. This transaction does not represent a sale by the reporting person.